Recent

% | $
Quotes you view appear here for quick access.

Cytori Therapeutics, Inc. Message Board

  • rothco619 rothco619 Jun 28, 2013 12:53 PM Flag

    It's Friday

    Another Friday and another test of the 52 week low. Sure hupe that there is something positive to come out of San Diego at some point. The cecond half of the year begins on Monday and mangement has promised a great second half of the year. Do we dare believe them ? History has proven them to be full of it. If the second half of the year is not super don't think we will be discussing Cytori this time next year just licking our wounds. Happy Friday

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • "Another Friday and another test of the 52 week low. Sure hupe that there is something positive to come out of San Diego at some point. The cecond half of the year begins on Monday and mangement has promised a great second half of the year. Do we dare believe them?" HA_Ha Ha Hee hee Hee Ho HO HOPE Ya SAY? !!!!!!!!!! Chris and his team remind me of the man with the untied shoelace...Walking, walking, walking, #$%$ tripped on shoelace! I guess I'll just get up and keep walking. I wonder how many times they will TRIP on that "SHOELACE" Before they figure out they should "TIE IT"!!!!!!!

    • CYTX used to be investors friendly. The long silence is very puzzling.

      If there is secondary coming, the PPS usually rises before hand, so that the MMs can get out to buy cheap shares later.

      The long silence may suggest something else.

      If there is a deal, I would guess the partner will be Japanese. CYTX can use the current Japanese "exposure" and income as a bait to bring in big money to support US clinical trials (phase 2 into phase 3, before the arrival of a big US partner). The settlement of the Olympus partnership and the GE debt restructuring may precede such a deal.

      PPS may rise sharply if the patient enrolment in the US Athena trial is completed this summer and if the EU approves the no option use of elution system in congestive heart failure (the EU submission for this indication was completed end of 2012). There are other positive news pending from Australia, Canada, etc.

      But, the company is silent in all fronts. Very puzzling indeed.

 
CYTX
2.17+0.12(+5.85%)Jul 29 4:00 PMEDT